TRIVETRIN

  • Product Details

Product Details - TRIVETRIN® INJECTION


Reg. No. G1742 Act 36/1947


Storage instructions:
Store in a cool, dark place.  Do not freeze.

Composition:
Trimethoprim 40 mg/mℓ, Sulfadoxine 200 mg/mℓ, Diethanolamine 3 mg/mℓ (preservative).

Indications:
Trivetrin is effective against a wide range of gram-positive and gram-negative organisms including Staphylococcus (including most penicillinase-producing strains), Streptococcus, Salmonella, E. coli, Haemophilus, Proteus, Pasteurella, Klebsiella  and  Enterobacter.

Trivetrin is indicated for the treatment of bacterial infections of the respiratory tract, urinary tract, genital tract and alimentary tract.  Trivetrin is also highly effective in the treatment of footrot, severe mastitis, bacterial agalactia of sows and the treatment of wound infections and septicaemias.

Warnings:
Milk from treated animals should not be used for human consumption within 48 hours of last treatment.

Animals should not be slaughtered for human consumption within 3 days of last treatment.

Trivetrin injection is not suitable for cats and kittens.

Do not administer to animals with a history of sulphonamide sensitivity or showing marked liver parenchymal damage.

Do not use Trivetrin in conjunction with detomidine hydrochloride.

Do not administer subcutaneously.

Keep out of reach of children, uninformed persons and animals.

Although this remedy has been tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons.  If this is suspected, seek veterinary advice and notify the registration holder. 

Directions for use - use only as directed:
Dosage and administration:

Route
Cattle, sheep and pigs:                   
Intramuscular injection
May be given by slow intravenous injection in cases of acute infection.

Dogs and horses:
Slow intravenous injection only. 

Dose
Normal: 1 mℓ/16 kg body mass daily (15 mg/kg)
Severe infection: 1 mℓ/10 kg body mass daily (24 mg/kg) 

Side-effects:
Occasionally local swellings of a temporary nature may develop at injection sites.

Known symptoms of overdosage:
None.

Presentation:
100 mℓ amber glass vial containing a clear solution.

Registration holder:

Schering-Plough Animal Health
Co. Reg. No. 1934/005207/07